SCI & TECH● ELEVATED1h ago · Oct 20, 2026, 6:27 PM
OpenAI acquires Orchestra Bio in AI push for new drugs
Seeking Alpha Tech · global
OpenAI has acquired Orchestra Bio as part of its strategic initiative to apply AI in the development of new drugs. This acquisition signifies a move into the biotechnology sector for the AI company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH11m agoMicrosoft plans next-generation Xbox, handheld devices for 2027-2028 holiday seasonsSeeking Alpha TechSCI & TECH31m agoDataVisor Cuts Financial Crime Solution Deployment from Months to Days with Agentic AItheobserver.ca · CanadaSCI & TECH1h agoNear Morris , Minnesota , a wind - powered ammonia plant adjusts fertilizer production with the breeze , targeting one metric ton dailyecoportal.net · United StatesSCI & TECH1h agoSpotify says it removed 50 million ‘slop’ and spam AI tracks this yearNBC News